🇺🇸 FDA
Patent

US 6627619

Antisense compositions for detecting and inhibiting telomerase reverse transcriptase

expired A61KA61K38/00A61K39/00

Quick answer

US patent 6627619 (Antisense compositions for detecting and inhibiting telomerase reverse transcriptase) held by The Regents of the University of Technology Office of Technology Transfer expires Mon Sep 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of Technology Office of Technology Transfer
Grant date
Tue Sep 30 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K38/00, A61K39/00, A61K48/00